Don’t Let a Poor Business Plan Crush Your MedTech Dreams

Turn your Project into an Investment Magnet with this FREE Tip Book

Hello

Thank you for taking the time to visit this site, I’ll only take a couple of minutes as I know your time it very valuable.

Here goes

In my 11 years of consulting for over 100 Medical Technology Companies from all over the world, I know the one thing that holds projects back time after time, funding. From small molecules and biotechnology to medical devices, they all have had their developments held up by funding issues.

Its not about the science

The projects that seem to have the least going for them scientifically and the ones that are so effective with such solid science it has you reaching for your own mortgage to back them. They all have the same delays, obtaining the funding; even the ones that are developed within Big Pharma have to justify their funding.

The winners are not those you think

The other big thing that I have noticed is that we can’t predict from the science or development burden which will get funding. No! there is a factor outside of all that, that does makes the difference.

Money magnets

There is a little something that makes all the difference and that is the business plan. It’s true, even the least likely projects with a great business plan seem to get funded whilst those projects that appear to be obvious candidates for cash, but have poor plans just never seem to make it out of the academic lab.

The X factor

So what did we decide to do? After spending a huge amount of time talking to funders and managers of successful projects and reading their business plans we have condensed all the wisdom into one little book.

Now at last you can make sure you have all your ducks lined up.

“available FREE for a limited time only; 117 Business Planning Tips for MedTech Entrepreneurs”

We have pulled out tips in the following areas:

Introducing your Technology : What do investors want to know, it’s not what you think.

Demonstrating Proof of Concept: Evidence that they can understand, and want to see

Indications not Mechanisms: It’s Indications that are opportunities not mechanisms of action

Orphan Indications: Investor benefits that can swing things

Early Cash: Soft sources smooth the path to big funding

Animal Work: What to do and what not to do

Licensing: Reality checks before bankers cheques

First in Man: Fast track development to fast track funding

Regulators: Greasing the funding with friendly regulators

Drug Delivery Technology: Know your opportunities and challenges

Intellectual Property: Adding value for the long term

Fill in the box now and make sure your technology isn’t left on the shelf. Its FREE for a limited time only, until the 13th May 2011, then a print edition will be available for purchase.